Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study


      Contrasting observations have been made between serum urate and ischemic stroke outcomes in studies involving Caucasian populations. To assess the hypothesis that urate is associated with stroke outcomes, a prospective follow-up study was performed in a cohort of Asian patients with ischemic stroke. Patients diagnosed with transient ischemic attack, first or recurrent ischemic stroke were included in this study. Serum urate, measured using high-performance liquid chromatography, was correlated with 12-month functional and vascular stroke outcomes. Poor functional outcome was defined as a modified Rankin scale exceeding 2 and vascular outcome was defined as a composite of recurrent stroke, myocardial infarction or vascular death during the study period. A total of 503 patients of mean age 63 (SD 12) years were included. A U-shaped relationship between urate quartiles and poor functional outcomes was demonstrated. More patients with low (<280 μM) and high (>410 μM) urate levels had poor functional outcomes (36% and 27% respectively), compared to those with urate levels between 340 and 410 μM (14%). No significant relationship was observed between urate and vascular outcomes. Depending on its level, serum urate may exhibit protective and deleterious effects on stroke outcomes.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Becker B.F.
        Towards the physiological function of uric acid.
        Free Radic Biol Med. 1993; 14: 615-631
        • Wu X M.D.
        • Lee C.C.
        • Caskey C.T.
        Two independent mutational events in the loss of urate oxidase during hominoid evolution.
        J Mol Evol. 1992; 34: 78-84
        • Cherubini A.
        • Ruggiero C.
        • Polidori M.C.
        • Mecocci P.
        Potential markers of oxidative stress in stroke.
        Free Radic Biol Med. 2005; 39: 841-852
        • Weir C.J.
        • Muir S.W.
        • Walters M.R.
        • Lees K.R.
        Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke.
        Stroke. 2003; 34: 1951-1956
        • Chamorro A.
        • Obach V.
        • Cervera A.
        • et al.
        Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke.
        Stroke. 2002; 33: 1048-1052
        • Bonita R.
        • Beaglehole R.
        Recovery of motor function after stroke.
        Stroke. 1988; 19: 1497-1500
        • Singapore Ministry of Health
        Health facts Singapore.
        • Bamford J.
        • Sandercock P.
        • Dennis M.
        • Burn J.
        • Warlow C.
        Classification and natural history of clinically identifiable subtypes of cerebral infarction.
        Lancet. 1991; 337: 1521-1526
        • Venketasubramanian N.
        • Tan L.C.
        • Sahadevan S.
        • et al.
        Prevalence of stroke among Chinese, Malay, and Indian Singaporeans: a community-based tri-racial cross-sectional survey.
        Stroke. 2005; 36: 551-556
        • Venketasubramanian N.
        • Yin A.
        Hospital costs for stroke care in Singapore.
        Cerebrovasc Dis. 2000; 10: 320-326
        • Rinaldi P.
        • Polidori M.C.
        • Metastasio A.
        • et al.
        Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.
        Neurobiol Aging. 2003; 24: 915-919
        • de Lau L.M.
        • Koudstaal P.J.
        • Hofman A.
        • Breteler M.M.
        Serum uric acid levels and the risk of Parkinson disease.
        Ann Neurol. 2005; 58: 797-800
        • Amaro S.S.D.
        • Obach V.
        • Cervera A.
        • Planas A.M.
        • Chamorro A.
        A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke.
        Stroke. 2007; 38: 2173-2175
        • Lehto S.N.L.
        • Ronnemaa T.
        • Laakso M.
        Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus.
        Stroke. 1998; 29: 635-639
        • Ginsberg M.H.
        • Kozin F.
        • O’Malley M.
        • McCarty D.J.
        Release of platelet constituents by monosodium urate crystals.
        J Clin Invest. 1977; 60: 999-1007
        • Mazzali M.
        • Kanellis J.
        • Han L.
        • et al.
        Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
        Am J Physiol Renal Physiol. 2002; 282: F991-F997
        • De Scheerder I.K.
        • van de Kraay A.M.
        • Lamers J.M.
        • et al.
        Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: potential mechanisms for free radical generation.
        Am J Cardiol. 1991; 68: 392-395
        • Abuja P.M.
        Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein.
        FEBS Lett. 1999; 446: 305-308
        • Johnson R.J.
        • Kang D.H.
        • Feig D.
        • et al.
        Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?.
        Hypertension. 2003; 41: 1183-1190
        • Ames B.N.
        • Cathcart R.
        • Schwiers E.
        • Hochstein P.
        Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.
        Proc Natl Acad Sci USA. 1981; 78: 6858-6862
        • Nieto F.J.
        • Iribarren C.
        • Gross M.D.
        • Comstock G.W.
        • Cutler R.G.
        Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?.
        Atherosclerosis. 2000; 148: 131-139